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A B S T R A C T
Carcinosarcoma of the anus is rare and has yet to be reportedly associated with the keratinocyte-speciﬁc Human
Papilloma Virus (HPV). We describe a case of anal carcinosarcoma with HPV infection in both the epithelial and
mesenchymal components of the tumor by immunohistochemistry, chromogenic in-situ hybridization (CISH)
and further supported by electron microscopy (EM). Microscopic examination of the tumor showed nests of
poorly-diﬀerentiated invasive squamous cell carcinoma with basaloid features intermixed with a hypercellular,
atypical spindle cell proliferation. Immunohistochemistry demonstrated that the epithelial component was
positive for AE1/AE3, p63, CK5/6 and p16, whilst the mesenchymal component was positive for smooth muscle
actin, vimentin, and focally positive for desmin and p16, consistent with carcinosarcoma. The tumor was
negative for GATA-3, CK7 and CK20. CISH demonstrated that the tumor was positive for high risk HPV
(subtype 16/18) in both tumor components. EM further supported the presence of intracellular virus particles
(~50 nm) that is compatible with HPV infection. Infection of both epithelial and mesenchymal tumor
components by HPV has not been previously observed in the gastrointestinal tract. This ﬁnding may represent
initial epithelial HPV infection with subsequent divergent tumoral diﬀerentiation and suggests the presence of
viral replication in both biphasic tumor components.
1. Introduction
Over 200 variants of the Human Papillomavirus (HPV) are now
recognized and most strains are considered to have a low or negligible
carcinogenic risk to humans [1,2]. HPV is epitheliotropic and common
sites of infection by the oncogenic forms of HPV include the transfor-
mation zone of the uterine cervix, vulva, oropharynx, anal canal and the
glans penis [3]. In the anal canal, HPV serotypes 6 and 11 are typically
associated with anal condylomas/ low grade anal intraepithelial
neoplasia (AIN) whereas high grade AIN and anal squamous cell
carcinoma (ASCC) has been linked to high risk HPV serotypes, such
as HPV 16 and 18 [4]. The most prevalent serotype in ASCC is HPV 16,
being found in up to 90% of cases [5,6].
In many of the areas that HPV can aﬀect, such as the uterine cervix,
glans penis, there have been documented cases of tumors that comprise
both epithelial and mesenchymal tumor elements (carcinosarcomas).
Several reports have described the presence of HPV infection in
carcinosarcomas of the uterine cervix and penis within both the
epithelial and mesenchymal components of these tumors [7–9].
There are rare instances of carcinosarcoma within the anal canal,
however to our knowledge, HPV infection in both epithelial and
mesenchymal components has yet to be reported [10]. We describe
the ﬁrst case of carcinosarcoma within the GI tract that has HPV
infection in both squamous and mesenchymal components. The
implications of this ﬁnding are discussed.
2. Case presentation
An 87-year-old man with a past medical history of hypertension,
hyperlipidemia and benign prostatic hypertrophy presented to his
physician with proctalgia. Examination under anesthesia revealed a
ﬁrm mass in the distal rectum. Biopsy tissue was obtained from the
rectum/ anus, ﬁxed in neutral-buﬀered formalin and prepared for
routine light microscopy. Immunoperoxidase and CISH were per-
formed targeting speciﬁc antigens and HPV DNA sequences, respec-
tively. Tissue for EM was then deparaﬃnized in xylene, rehydrated in
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alcohol, post-ﬁxed in Osmium Tetroxide and embedded in Epox A12.
Ultrathin sections were cut at 70 nm and stained with uranyl citrate
and lead citrate. EM was performed on a JEM 1010 microscope.
2.1. Histology
Microscopic examination of the tumor revealed a biphasic tumor
comprising nests of poorly-diﬀerentiated invasive squamous cells with
intervening atypical spindle cells (Fig. 1A). The squamous component
exhibited a basaloid phenotype. Immunohistochemistry using immu-
noperoxidase stains on paraﬃn embedded tissue demonstrated that
the epithelial component was positive for AE1/AE3, p63 (Fig. 1B),
CK5/6, whilst the mesenchymal component was positive for smooth
muscle actin (Fig. 1C), vimentin, and focally positive for desmin,
consistent with carcinosarcoma (leiomyosarcoma). Of interest, both
components exhibited p16 reactivity, suggesting possible HPV involve-
ment in both tumor elements (Fig. 1D). The tumor was negative for
GATA-3, CK7 and CK20..
2.2. In-situ hybridization
CISH was performed against HPV subtypes 6, 11, 16, 18, 31 and 33.
Both epithelial and mesenchymal tumor cells showed an even, dot-like
staining pattern within the tumor nuclei of high risk HPV (subtypes
16/18) (Fig. 1E). This ﬁnding conﬁrmed the presence of the same HPV
subtype in both tumor components and its integration into the cellular
Fig. 1. : A) Hematoxylin and eosin stained sections show nests of neoplastic epithelial cells with intervening atypical spindle cells compatible with carcinosarcoma, x100. B) The
epithelial component of the carcinosarcoma was reactive against p63 antibody, x100. C) The mesenchymal component was reactive to smooth muscle actin, x100. D) Both epithelial and
mesenchymal tumor components exhibited p16 immunoreactivity, x100. E) HPV 16/18 probes show dot-like signals in both epithelial and mesenchymal components of the tumor,
x400. F) Ultrastructural examination of the tumor reveals intracellular particles that are approximately 50 nm in maximal dimension arranged in a lattice formation.
R.A. Hickman et al. Papillomavirus Research 2 (2016) 164–166
165
genome.
2.3. Ultrastructural ﬁndings
Ultrastructurally, the tumor exhibited squamous diﬀerentiation.
Electron-dense particles that measured approximately 50 nm in size
were identiﬁed and were arranged in a lattice conﬁguration (Fig. 1F).
This size and arrangement is compatible with the HPV virus. Although
evident microscopically, identiﬁcation of mesenchymal diﬀerentiation
was limited by tissue quantity and post-embedding deparaﬃnization.
3. Discussion
This report demonstrates viral infection by HPV of both epithelial
and mesenchymal components of a carcinosarcoma conﬁrmed by
immunohistochemistry and in-situ hybridization. Whilst HPV infection
of keratinocytes has been well documented in various body sites with
squamous epithelia, it has been only rarely described in biphasic
tumors, predominantly in the gynecologic tract and in several cases
of the genitourinary tract. The presence of HPV 16/18 by ISH
demonstrates viral infection within the tumor cells and p16 immunor-
eactivity in the tumor suggests viral transformation, likely through
inactivation of pRB through E7 oncoprotein expression. To our knowl-
edge, this case is the ﬁrst example of HPV in both biphasic tumor
elements of carcinosarcoma within the GI tract.
The following explanations as to the histogenesis of carcinosarcoma
have been proposed: 1) that carcinosarcoma is a collision tumor of two
distinct epithelial and mesenchymal tumors, 2) that the mesenchymal
component is a reactive stromal response to the malignant epithelial
component and 3) that it arises from a monoclonal tumor cell that
diﬀerentiates into epithelial and mesenchymal tissue types [11].
Although it is recognized that bovine papillomavirus has the ability
to infect both epithelial and mesenchymal tissues, the infectivity of
HPV is thought to be conﬁned to epithelial tissues, which disputes that
this case was a collision tumor or a reactive phenomenon [12]. Rather,
the ﬁnding of high-risk HPV in both epithelial and mesenchymal
components, suggests that initial HPV infection of the anal squamous
mucosa occurred, which as the tumor grew, a subpopulation of tumor
cells diﬀerentiated into a mesenchymal phenotype with retention of
HPV infection. This has been the prevailing hypothesis for cases of
cervical carcinosarcoma with HPV infection [9,13,14].
Although the general prognosis of anal carcinosarcoma is poor, in
our case, the patient remains disease-free at 1 year follow-up after
chemoradiotherapy which included a daily radiotherapy dose of
180 cGy up to a total dose of 5400 cGy [15]. It is recognized that p16
positive ASCC are more radiosensitive and have improved recurrence
free survival and overall survival compared with p16 negative ASCC
[5,6]. One could infer from this that immunoreactivity to p16 in at least
the squamous component of this leiomyosarcoma may have resulted in
better response to radiotherapy and thus improved survival, however,
larger studies are needed in p16 positive leiomyosarcomas at this
location. Given that this tumor was associated with HPV subtypes 16
and 18, future cases such as this might be avoided by HPV vaccination
prior to infection [16].
4. Conclusion
To our knowledge, this is the ﬁrst case of carcinosarcoma in the GI
tract that has HPV infection within both the epithelial and mesench-
ymal components. Given the epitheliotropic nature of HPV, this ﬁnding
supports divergent tumoral diﬀerentiation as a plausible pathway in
the development of this tumor.
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